Germany ophthalmic viscosurgical devices market to register substantial gains over 2016-2024, high prevalence of eye disorders to drive the demand
Ophthalmic viscosurgical devices market is expected to carve a remarkable growth path, owing to the surging product requirement for age-related cataract treatment. Reliable statistics state that more than 10 million cataract operations are carried out across the globe. According to Global Market Insights, Inc., “Worldwide ophthalmic viscosurgical devices market will surpass a revenue collection of USD 790 million by 2024 with an annual growth rate of more than 10% over the years ahead.” Increasingly changing dietary habits and a hectic, modern lifestyle has led to a widespread occurrence of diabetes. Diabetic people are vulnerable to ocular disabilities such as blindness and diabetic retinopathy, which in turn, will favor ophthalmic viscosurgical devices industry growth noticeably.
U.S. Ophthalmic Viscosurgical Devices Market Size, By Application, 2012-2024 (USD Million)
Based on the products, ophthalmic viscosurgical devices market is mainly divided into cohesive, dispersive, and combined. Dispersive devices covered more than 47% of the revenue share in 2015 and will exhibit lucrative growth prospects over the coming years of 2016 to 2024. The prominent usage of these devices for cataract surgeries due to their notable rheological characteristics will augment the product demand. Cataract surgery application acquired more than 49% of the market share of the application landscape in 2015 and will record a CAGR of 12.6% over the period of 2016 to 2024. The number of patients affected by cataract are increasing substantially across the globe, which will noticeably boost the demand for ophthalmic viscosurgical devices.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1134
Cohesive ophthalmic viscosurgical devices market is anticipated to cover a market share of about 40% over the coming years of 2016 to 2024, owing to the cohesive nature of the device, which is mainly used in OVD retention for phacoemulsification. Phacoemulsification technology is extensively used for the treatment of cataract.
Vitreoretinal surgery is another attractive application segment of ophthalmic viscosurgical devices market. Vitreoretinal surgery was worth more than USD 53 million in 2015 and will cross a revenue collection of USD 150 million by 2024. The growth can be attributed to the surging need of these devices in diabetic retinopathy, macular degeneration, and diabetic vitreous haemorrhage.
Geographically, Germany ophthalmic viscosurgical devices market will register an annual growth rate of 11.9% over the period of 2016 to 2024, owing to the growing awareness regarding eye-related disorders such as cataracts among the rising geriatric population.
U.S. ophthalmic viscosurgical devices industry was worth more than USD 110 million in 2015 and will exhibit significant growth rate over the years ahead. The growth can be attributed to the growing occurrence of ophthalmic ailments such as diabetic retinopathy, cataract, and glaucoma. In addition, the availability of advanced healthcare facilities and supportive reimbursement policies will augment the industry growth noticeably.
Japan ophthalmic viscosurgical devices market collected a revenue of over USD 12 million in 2015 and will cross a market value of USD 41 million by 2024, primarily driven by the invasively growing geriatric population.
Industry giants will focus on product differentiation, strategic partnerships, and new product launches to sustain their position in the market. Top business competitors occupied more than 50% of the revenue share in 2015. Key participants in ophthalmic viscosurgical devices market are Abbott Medical Optics Inc., Alcon, Bausch & Lomb, Carl-Zeiss, Hyaltech Ltd., CIMA Technology, Inc., Rayner, and Precision Lens.
Author Name :Sunil Hebbalkar
Portable homecare oxygen concentrators market to witness phenomenal gains over the years ahead, APAC slated to record the fastest growth
Homecare oxygen concentrators market is witnessing a significant upsurge, driven by the rising number of chronic obstructive pulmonary disease (COPD) patients across the globe. A considerable increase in the number of cigarette smokers and rising exposure to pollution and dust will increase the prevalence of COPD among people. Moreover, the geriatric population is more susceptible to respiratory diseases such as asthma, pulmonary hypertension, fibrosis and are likely to push the growth of homecare oxygen concentrators industry over the years. According to Global Market Insights, Inc., Homecare Oxygen Concentrators Market is projected to witness a CAGR of 12% over the period of 2016-2023 with a revenue target of USD 1.5 billion by 2023.
Product innovation in this market is likely to gain considerable traction with the growing demand for flow technology. Portable oxygen concentrators, liquid oxygen, compressed gas oxygen cylinders are the three trending homecare oxygen concentrators product segments. Compressed gas oxygen cylinder is estimated to generate a revenue of over USD 57 million by 2023, owing to its availability in varied sizes based on the oxygen level requirements. However, the explosion risks associated with these devices coupled with their heavy weight may impede the device market expansion over the coming years.
Germany Homecare Oxygen Concentrators Market size, by product, 2012-2023 (USD Million)
Combating the disadvantages such as heavyweight and complex designs, portable homecare oxygen concentrators are witnessing an appreciable adoption rate. Portable homecare oxygen concentrators industry held a major share of over 75% of the global product landscape, and is projected to register a CAGR of 10% over the period of 2016-2023. The compact size of this device and light weight are the complementing factors attracting major revenue for this market.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1205
U.S. almost covered 88% of North America’s homecare oxygen concentrators industry share in 2015 and is slated to attain stupendous growth over the years ahead. Increasing incidence of pulmonary diseases, especially across the elderly population is driving the demand for home health care, which in turn is providing ample opportunities to the regional market. Additionally, favorable insurance policies which cover a large portion of device cost is further acting as a catalyst for the growth trajectory path of the homecare oxygen concentrators market.Huge geriatric base, upgraded living standards, and technologically advanced healthcare infrastructure are the key factors behind the rapid expansion of the APAC homecare oxygen concentrators market. China, India, and Japan are expected to be the major revenue pockets of the regional market.
Japan homecare oxygen concentrators industry generated a revenue of USD 52 million in 2015 and is estimated to cross over USD 138 million by 2023. With strategic collaborations and continuous product upgradation, Asia Pacific market is poised to record maximum growth rate in the coming time frame.
Germany dominated the Europe homecare oxygen concentrators market in 2015, accounting for almost 31% of the regional revenue with a market value of USD 54 million. In the coming time frame too, this country is estimated to experience a striking growth curve at a CAGR of 10% over 2016-2023. Sheer consumer demand for upgraded health care services along with a good number of market players’ availability is stimulating the business expansion in this region.
Continuous efforts on improving the product portfolio and mergers & acquisitions are the major strategies adopted by the industry players to sustain their market position. Some of the prominent players of homecare oxygen concentrators market include Teijen, Covidien, Invacare, Precision Medical, and AirSep.
Author Name :Ojaswita Kutepatil
U.S. to lead global protein A resins market landscape over 2016-2024, technological advanced clinical infrastructure to drive the regional growth
The increasing usage of monoclonal antibodies for therapeutic and diagnostic purposes will multiply Protein A resins market revenue in the years ahead. Industry players are focusing on manufacturing copious quantities of biosimilars to reduce the escalating medicine costs, which depicts a positive growth for the industry. Beneficial government norms supporting production of biosimilars will also spur the global demand for the products. As per Global Market Insights, Inc., “Protein A Resins Industry, which accumulated a revenue of USD 440 million in 2015, is slated to surpass USD 900 million by 2024.”
Protein A resins are extensively used in antibody purification and immunoprecipitation processes. Antibody purification application segment is forecast to hit USD 700 million by 2024 and will contribute notably towards protein A resins industry size. Enhanced use of antibodies for diagnosing and treating dreaded diseases will push the revenue.
Immunoprecipitation, which contributed over 20% of protein A resins market share in 2015, is forecast to record a CAGR of 8% over the period of 2016 to 2024. Escalating usage of protein A resin products in purifying specified composites will help the industry to progress rapidly.
Japan Protein A Resin Market size, by matrix type, 2012-2024 (USD Million)
Contract research organizations, biopharmaceutical firms, academic research institutions, and clinical research institutes are the prominent end-use industries that extensively use protein A resins. Protein A resins market size from contract research organizations (CRO) is forecast to surpass USD 130 million by 2024, growing at an annual rate of 8.1% over 2016-2024. Massive outsourcing of protein purification processes by pharmaceutical & biotechnology firms and academic institutes will complement the growth.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1146
Biopharmaceutical firms, which contributed more than 75% of protein A resins industry share in 2015, will hit a revenue margin of over USD 680 million by 2024. Global requirement for monoclonal antibodies for efficient diagnosis will augment the revenue.
Based on the product trends, protein A resins industry is classified into natural protein A resins and recombinant protein A resins. Natural protein A resins market is forecast to grow at a rate of 8% over 2016-2024 and will hit revenue of over USD 580 million by 2024. Highly beneficial product characteristics such as enhanced antibody production, convenient operation, and antibody purification will augment the growth.
Taking into consideration the regional trends, APAC protein A resins market is expected to record a CAGR of 8.5% over the period of 2016-2024. Beneficial legislations, reasonably developed healthcare infrastructure, and the easy availability of experts has prompted many CROs and biopharmaceutical firms to set up their business in the region. Japan protein A resins industry, worth USD 37 million in 2015, is intended to reach USD 78 million by 2024.
U.S. protein A resins industry, which accounted for over 85% of North America protein A resins market revenue in 2015, will witness a remarkable expansion over the coming years. A robust clinical infrastructure coupled with stringent government regulations regarding the usage of protein A resin products will play a vital role in shaping the business across the region.
Mexico protein A resins market is forecast to grow at a rate of 8% over the period of 2016-2024 and will drive the LATAM industry size. Growing use of monoclonal antibodies in clinical research activities is expected to impel the revenue.
Considering the matrix trends, protein A resins industry is segmented into organic polymer, agarose, and glass/silica gel. Agarose-based matrix, which contributed over 80% of protein A resins market size in 2015, is intended to record an annual growth of 8.3% over the period of 2016-2024, driven by ligand binding stability of this particular matrix. Silica gel based matrix is expected to register considerable gains of 8.4% over the coming seven years.
Strategic collaborations and product innovations are a couple of important business strategies adopted by leading companies to increase their return on sales and expand their business. Key industry participants include Danaher Corporation, Purolite Life Sciences, Novasep Holding SAS Company, GE Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories Incorporation, Sigma-Aldrich Corporation, GenScript Biotech Corporation, Agarose Bead Technologies, Takara Bio Incorporation, Expedeon Limited, and Merck Millipore Corporation.
Author Name :Dhananjay Punekar
Digital genome market to observe lucrative gains via R&D sector, U.S. to stimulate industry growth over 2016-2024
On-going research activities along with supportive regulations across the globe will revolutionize digital genome market. The growing implementation of this technology in the field of personalized medical care for efficient disease management will noticeably favor digital genome industry share. According to the Global Market Insights, “Worldwide digital genome market was worth USD 20 billion in 2015 and will exhibit a CAGR of about 9.5% over the coming years of 2016 to 2024.”
The prominent applications of digital genome industry are microbiology, reproductive & genetic, research & development, transportation, and livestock & agriculture sectors. Microbiology application segment accounted for more than 22% of the revenue share in 2015 and will surpass a revenue collection of USD 10 billion by 2024. The growing demand for microbes across clinical, biological, and industrial sectors should drive the revenue. Research & development dominated the application landscape in 2015 and will contribute a revenue of more than USD 23 billion by 2024. The growth can be attributed to heavy investments by private and public sector firms in research activities.
Germany Digital Genome Market size, by product, 2012-2024 (USD Million)
Sequencing and analysis software, one of the product bifurcations of digital genome market, will register an annual growth rate of 9.8% over the period of 2016 to 2024, owing to the increasing efforts to upgrade software packages. High investments in life science research will favor sequencing and analyzer instrument industry, which covered more than 40% of the global digital genome market contribution in 2015. Sample prep instruments, sequencing chip, and RNA or DNA analysis kits are the other notable products in digital genome industry.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1219
China digital genome market size will grow at an annual growth rate of more than 10% over the period of 2016 to 2024. The growth can be attributed to the supportive governmental activities in the favor of human genetic development. Moreover, the strategic partnerships between the biobanks and research institutes will influence the industry share noticeably.
U.S. digital genome market covered over 80% of the North America regional share in 2015 and will generate significant revenue over the coming seven years, owing to the genome sequencing technological enhancements along with availability of advanced healthcare infrastructure.
Brazil digital genome market is anticipated to record a considerable growth rate over the coming timeframe. The supportive rules and regulations regarding genetic and clinical testing will augment the business growth.
Russia digital genome market collected a revenue of around USD 290 million in 2015 and will exhibit lucrative growth over the coming years of 2016 to 2024, primarily driven by the fierce competition prevalent in the region. The Genome Russia project launched by St. Petersburg State University in Russia, aims to collect and scrutinize genome sequences from different regions across the country, which is also expected to generate a noticeable revenue over the coming seven years.
Collaborations, acquisitions, and novel product innovations are the business growth strategies of industry giants. The corporations operating in digital genome market are Becton Dickinson, Agilent Technologies, Qiagen, Thermo Fisher Scientific, Illumina, Pacific Biosciences, Perkin Elmer, Sigma-Aldrich, BioMarin Pharmaceutical, Fluidigm Corporation, Bio-Reference Laboratories, AVEO Oncology, and Agios.
Author Name :Sunil Hebbalkar
Apheresis Equipment Industry to gather an appreciable share via neurology applications, U.S. to be a major revenue pocket
Beneficial medical compensation plans for apheresis procedures will be one of the key factors accelerating apheresis equipment market growth. Industry experts are heavily involved in strategic mergers & acquisitions and novel product launches to sustain the competition. Just recently, Terumo, a world leader specializing in cellular and apheresis technology, announced the launch of an innovative apheresis device to treat Myasthenia Gravis (MG) disease and Guillain-Barré syndrome. This device, named Spectra Optia Apheresis System is the first and only device of its kind in Europe that is enabled to treat the aforementioned disorders by means of therapeutic plasma exchange.
The U.S. government makes heavy investments in apheresis research through Medicare, employee insurance, and Medicaid programs. High expenditure on research activities coupled with a steep rise in the number of platelet donors will boost apheresis equipment industry trends. With the introduction of technological advancements, the demand for innovative apheresis devices is expected to surge as well. As per Global Market Insights, Inc., “Apheresis Equipment Industry, which was valued at USD 1.7 billion in 2015, is forecast to hit USD 4.5 billion by 2024.”
U.S. Apheresis Equipment Market Size, by procedure, 2012- 2024 (USD Million)
High incidences of blood-related disorders such as leukemia and sickle cell anemia coupled with the bulging need for innovative blood component separation techniques will chalk out a profitable roadmap for apheresis equipment industry. An increase in the rate of surgical procedures performed pertaining to the rise in the number of accidents is anticipated to make notable contributions towards the apheresis market revenue.
Apheresis equipment is extensively used in the treatment of neurology, renal diseases, and hematology. Neurology, which accounted for half of apheresis equipment market revenue in 2015, will grow at an annual rate of 12.3% over 2016-2024. Increased occurrence of neurological disorders such as autoimmune disease and multiple sclerosis will drive apheresis equipment industry in neurology applications.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/847
Based on the product trends, apheresis equipment market is classified into disposable apheresis kits and apheresis machines. Disposable apheresis kits dominated the product landscape with a contribution of more than 78% toward apheresis equipment industry share in 2015. Growing popularity along with significantly lower costs will drive the product demand, leading to disposable apheresis equipment market earning a revenue of USD 2,944 million by 2024. Apheresis machines are expected to register significant gains of 17.1% over the coming seven years, driven by escalating requirement for automated component separation equipment.
Europe apheresis equipment market was worth USD 365 million in 2015 and will collect a revenue of more than USD 1,084 million by 2024, owing to the implementation of supportive rules and regulations. Industry giants are also keen to expand their business space across this region, making it an attractive growth avenue. UK and Germany together accounted for more than 27% of the revenue share in 2015.
U.S. apheresis equipment industry contributed majorly toward the North America market size by exceeding a share of 87% in 2015 and will exhibit an annual growth rate of more than 9% over the period of 2016 to 2024. The growth can be attributed to the increasing requirement of automated and technically enhanced products across this region. In addition, the availability of subsidies and refund facilities will also augment the industry growth.
Asia Pacific apheresis equipment market share will generate more than USD 1,265 million by 2024, primarily driven by the surging demand for platelets and plasma pertaining to the increasing prevalence of blood disorders across the emerging countries such as China and India. Japan will also contribute noticeably toward the APAC regional growth as a result of rising adoption of advanced apheresis products along with growing occurrence of cardiovascular diseases.
Strategic partnerships, M&As, and global expansion with major focus on the emerging economies are some of the major business growth strategies adopted by the industry giants. Notable participants in apheresis equipment market are Fresenius Kabi, B.Braun Melsungen, Terumo Corporation, Haemonetics, Kawasumi Laboratories, Therakos, Fenwal Inc, and Hemacare Corporation.
Author Name :Sunil Hebbalkar
China Hydraulic Cylinder Market to witness substantial gains over 2016-2025, heavy investments toward infrastructural development to augment the regional growth
Hydraulic Cylinder Market will chart out a lucrative growth path, given that hydraulic cylinders form the backbone of various commercial and industrial applications. These cylinders are also used to manufacture agricultural equipment to enhance agricultural productivity, which will significantly enhance hydraulic cylinder industry growth. In addition, the high rate of investments by developing economies such as India and China are also expected to contribute to the overall business expansion. As per the report by Global Market Insights, Inc., “Hydraulic cylinder market generated a revenue of USD 10 billion in 2015 and will grow at an annual growth rate of more than 6% over the period of 2016 to 2025.”
U.S. Hydraulic Cylinder Market size, by application, 2013 -2025 (Million Units)
The prominent application areas of hydraulic cylinder industry are industrial and mobile. Industrial application segment accounted for more than 32% of the revenue share in 2015 and will exhibit a CAGR of above 4% over the coming eight years. Mobile hydraulic cylinder industry dominated the application landscape in 2015 and will generate significant revenue over the years ahead, owing to the increasing product requirement for material handling and agricultural equipment. Additionally, escalating urbanization and increasing construction activities will augment the industry.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/814
Based on the product, hydraulic cylinder market is mainly divided into welded and tie rod. Welded hydraulic cylinder industry will surpass a revenue collection of USD 11 billion by 2025. The extensive use of this product in the construction, mining, industrial, and material handling sectors will augment the market growth noticeably. The surging expansion of the agricultural equipment industry will propel the demand for tie rods, which will grow at an annual growth rate of more than 6% over the period of 2016 to 2025.
Double acting and single acting are the main functional trends of hydraulic cylinder industry. Double acting hydraulic cylinder will collect a revenue above USD 11 billion by 2025, primarily due to the usage of double acting hydraulic cylinders in applications where gravity is the prominent factor, affecting the acceleration and retardation. In addition, double acting function based hydraulic cylinders are extensively used for heavy trucks, forklifting, and earth moving equipment, which will considerably drive overall hydraulic cylinder market share. Single acting hydraulic cylinder market was worth USD 3.12 billion in 2015 and will record substantial growth rate over the coming timeframe.
Geographically, U.S. hydraulic cylinder industry is predicted to generate a revenue of more than USD 3 billion by 2025, owing to heavy investments in the material handling, defense, and aerospace sectors.
China hydraulic cylinder market will collect a revenue of more than USD 1 billion by 2025. The growth can be attributed to the increasing expenditure in infrastructure development. In the years ahead, the Chinese government is willing to invest around USD 151 million in Hubei Xiaogan logistics infrastructure project.
Brazil hydraulic cylinder industry will exhibit an annual growth rate of more than 4% over the period of 2016 to 2025, primarily driven by rising investments in the transportation sector. Russia hydraulic cylinder market will also register a CAGR of more than 3% over the coming eight years. The growth can be attributed to the surging requirement of construction and agricultural equipment.
The key participants in hydraulic cylinder market are Bosch Rexroth AG, Wipro Infrastructure Engineering, Aggressive Inc, Hannon LLC, Best Metal Products, Ligon Industries, LLC, Eaton Corporation PLC, Prince Manufacturing Corporation, Hydrapac Italia, YELETSGIDROAGREGAT, chapel hydraulique, United Hydraulics, Burnside Autocyl (Tullow) Ltd., Bailey International LLC, Enerpac Corp., Baltic, Hyco International, Inc., Caterpillar Inc., Precision group Inc., Norrhydro Oy, Parker-Hannifin Corporation, Weber-Hydraulik Group, Pacoma GmbH, Texas Inc, and Hydrosila.
Author Name :Sunil Hebbalkar
Fiber Advanced Polymer Composites Market to accrue a massive share over 2016-2024, Asia Pacific to be the fastest-growing region
Advanced Polymer Composites Market graph will display an upward swing, driven by its extensive use in the aviation sector subject to exceptional product features such as abrasion resistance and robustness. Polymer composites are used to manufacture aircraft components, owing to which they find applications in commercial and passenger aviation sectors. They are also used to manufacture wind blades that are utilized in wind energy production. In fact, overall power generating capacity of wind blades, which was 3,00,000 MW, is likely to hit 7,50,000 MW by 2024. The escalating usage of composites to manufacture wind blades and the mounting wind energy requirement will further boost the growth of advanced polymer composites market. According to Global Market Insights, Inc.,” Advanced Polymer Composites Industry revenue will probably surpass USD 16 billion by 2024, growing at a CAGR of 7% over 2016-2024.”
Taking into consideration the regional trends, North America advanced polymer composites industry, which collected a revenue of USD 3 billion in 2015, is anticipated to positively influence the business space. Massive demand for automobiles plus the growing preference for power generation via wind blades will drive the industry growth. Flourishing aerospace sector in the U.S. will contribute massively towards the regional revenue.
U.S. Advanced Polymer Composites Market Size, By Application, 2013 – 2024 (USD Million)
Asia Pacific advanced polymer composites market share is predicted to expand strikingly, during the period of 2016 to 2024. Rise in the aircraft sales and growing number of construction activities are expected to raise the industry revenue. India and China are likely to make hefty contributions towards the regional share.
Get a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/1175
Advanced polymer composites also find extensive applications in boat building, auto parts, tanks & pipes, conductors, and aviation parts. Advanced polymer composites industry share from the auto parts sector is slated to grow at an annual rate of 7% over 2016-2024. Increase in automobile production and subsequent sales will push the growth.
Advanced polymer composites market size in aviation parts sector, which accumulated a revenue of USD 3.5 billion in 2015, will witness a significant surge in the years ahead. High product preference across the aerospace industry will profit the business.
Fibers and resins are the major industry products. Fiber based advanced polymer composites industry, which dominated the product landscape in 2015, is expected to grow substantially over the years to come. The growth can be attributed to its extensive application across the marine, aerospace and automotive sectors. Resins based advanced polymer composites market, which was estimated at USD 3 billion in 2015, will observe a notable growth in future. These products find wide applications in boat building, metal bonding, aviation parts, and carbon & electrical materials.
Market participants will try to establish their global presence through hefty R& D investments, new product launches, and strategic alliances. Cytec Industries Incorporated, Kemrock Industries and Exports Limited, BASF SE, SGL Carbon SE, Arkema S.A, 3B-Fibreglass sprl, Toray Industries Incorporation, Koninklijke Ten Cate NV, Mitsubishi Rayon Company Limited, Owens Corning Company, Cristex Limited, Solvay S.A, TPI Composites Incorporation, and Hexcel Corporation are the major players of advanced polymer composites industry.
Author Name :Dhananjay Punekar